Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.Multiple Sclerosis and Related Disorders|July 9, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemicAnibal Chertcoff, Johana Bauer, Berenice Anabel Silva, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.Journal of Neurology|September 7, 2021
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEMJuan I Rojas, Agustín Pappolla, Patricio Blaya, et al.Multiple Sclerosis and Related Disorders|August 27, 2023
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in ArgentinaRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2022
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in ArgentinaJuan I Rojas, Agustín Pappolla, Liliana Patrucco, et al.Multiple Sclerosis and Related Disorders|June 5, 2021
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAMJuan I Rojas, Edgar Carnero Contentti, Patricio Abad, et al.Journal of the Neurological Sciences|December 10, 2019
Consensus recommendations on the management of multiple sclerosis patients in ArgentinaEdgardo Cristiano, Juan Ignacio Rojas, Ricardo Alonso, et al.Pageof 6